Apolipoprotein A1 Infusions After Acute MI Disappoint in Phase III Trial

Source link : https://www.newshealth.biz/health-news/apolipoprotein-a1-infusions-after-acute-mi-disappoint-in-phase-iii-trial/

ATLANTA — Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other cardiovascular risk factors, the large international AEGIS-II study showed. The primary endpoint — MI, stroke, or cardiovascular death through 90 days — was not significantly different between the group randomized […]

Author : News Health

Publish date : 2024-04-08 18:23:00

Copyright for syndicated content belongs to the linked Source.